Sierra Oncology Stock Price, News & Analysis
Company Description
Sierra Oncology (NASDAQ: SRRA) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.3B.
SRRA stock has gained 182.4% over the past year.
This page provides a comprehensive overview of SRRA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sierra Oncology (SRRA) stock. Over the past 12 months, the stock has gained 182.4%. At a market capitalization of $1.3B, SRRA is classified as a small-cap stock with approximately 24.4M shares outstanding.
Latest News
Sierra Oncology has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, earnings, management, acquisition, conferences. View all SRRA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SRRA Company Profile & Sector Positioning
Sierra Oncology (SRRA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing SRRA often look at related companies in the same sector, including Syndax Pharmaceuticals Inc (SNDX), Abcellera Biologics Inc. (ABCL), Novavax Inc (NVAX), Stoke Therapeutics (STOK), and 89Bio, Inc. (ETNB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SRRA's relative position within its industry.